NYPOZI Trademark

Trademark Overview


On Friday, April 29, 2022, a trademark application was filed for NYPOZI with the United States Patent and Trademark Office. The USPTO has given the NYPOZI trademark a serial number of 97388041. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Thursday, October 31, 2024. This trademark is owned by Tanvex BioPharma, Inc.. The NYPOZI trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for use in stimulating white blood cell production and pharmaceutical preparations for the treatment of cancer and of blood disorders and conditions, including those caused by cancer treatments
nypozi

General Information


Serial Number97388041
Word MarkNYPOZI
Filing DateFriday, April 29, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateThursday, October 31, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 28, 2023

Trademark Statements


Goods and Servicespharmaceutical preparations for use in stimulating white blood cell production and pharmaceutical preparations for the treatment of cancer and of blood disorders and conditions, including those caused by cancer treatments

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 4, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTanvex BioPharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGrand Cayman KYI-1205
KY

Party NameTanvex BioPharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGrand Cayman KYI-1205
KY

Trademark Events


Event DateEvent Description
Tuesday, May 3, 2022NEW APPLICATION ENTERED
Wednesday, May 4, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 17, 2023ASSIGNED TO EXAMINER
Wednesday, February 22, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 28, 2023PUBLISHED FOR OPPOSITION
Tuesday, March 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 23, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, November 2, 2023SOU TEAS EXTENSION RECEIVED
Thursday, November 2, 2023SOU EXTENSION 1 FILED
Thursday, November 2, 2023SOU EXTENSION 1 GRANTED
Saturday, November 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 26, 2024SOU EXTENSION 2 FILED
Friday, April 26, 2024SOU TEAS EXTENSION RECEIVED
Friday, April 26, 2024SOU EXTENSION 2 GRANTED
Thursday, October 31, 2024SOU TEAS EXTENSION RECEIVED
Thursday, October 31, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 31, 2024SOU EXTENSION 3 GRANTED
Thursday, October 31, 2024SOU EXTENSION 3 FILED
Saturday, April 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED